Vogenx

Durham, United States

Vogenx is a clinical stage drug development company focusing on treatment of diseases associated with dysfunctions in human metabolism

$750K raised

Jan 2026

Debt Financing

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vogenx

How much funding has Vogenx raised?

Vogenx has raised $750K in total funding. The most recent round was Debt Financing. The last funding was announced in January 2026.

Where is Vogenx headquartered?

Vogenx is headquartered in Durham, United States.

What does Vogenx do?

Vogenx is a clinical stage drug development company focusing on treatment of diseases associated with dysfunctions in human metabolism

What stage is Vogenx at?

Vogenx is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 6, 2026.

MLA

"Vogenx — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/vogenx. Accessed July 2, 2026.

APA

VCBacked. (2026). Vogenx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vogenx

Wikipedia (cite web)

{{cite web |title=Vogenx — Funding & Investors |url=https://www.vcbacked.co/company/vogenx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 6, 2026.